{"id":"W2518324907","doi":"10.1182/blood.v114.22.430.430","title":"Carfilzomib (CFZ), a Novel Proteasome Inhibitor for Relapsed or Refractory Multiple Myeloma, Is Associated with Minimal Peripheral Neuropathic Effects.","year":2009,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Calgary; Princess Margaret Cancer Centre","funders":"","keywords":"Carfilzomib; Proteasome inhibitor; Medicine; Bortezomib; Discontinuation; Adverse effect; Internal medicine; Multiple myeloma; Peripheral neuropathy; Refractory (planetary science); Oncology; Pharmacology; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004661257,0.0003858599,0.0007851383,0.0002381415,0.0002515182,0.0002460142,0.0003412921,0.0004124329,0.001179678],"category_scores_gemma":[0.0004488024,0.0001273272,0.0003152821,0.0003185858,0.0002567867,0.0002419614,0.0001459818,0.0008932516,0.0002694293],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005616575,"about_ca_system_score_gemma":0.0004054308,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001005144,"about_ca_topic_score_gemma":0.005605657,"domain_scores_codex":[0.9998451,0.00004065781,0.00001028183,0.00002627896,0.00003161684,0.00004610201],"domain_scores_gemma":[0.9997929,0.00005804235,0.00004431867,0.00001895918,0.00001169295,0.00007406808],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"observational","study_design_scores_codex":[0.05115461,0.007960387,0.03520129,0.001372359,0.0006777891,0.005951779,0.0004324377,0.001695197,0.3195444,0.0005883589,0.01158882,0.5638325],"study_design_scores_gemma":[0.05543524,0.3261922,0.4449055,0.0001387138,0.001103097,0.03802681,0.0001604938,0.004274336,0.06752078,0.0004017061,0.06176258,0.00007851209],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9828376,0.01204401,0.0006746136,0.0005392478,0.00008241743,0.0003643565,0.0004613091,0.0001442548,0.002852384],"genre_scores_gemma":[0.995596,0.002122913,0.000527112,0.0002637604,0.00005198578,0.00008486344,0.0007403393,0.000007853231,0.000605203],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001179678,"threshold_uncertainty_score":0.00407511,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02275757229499013,"score_gpt":0.275534983373577,"score_spread":0.2527774110785869,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}